Home - Products - Others - Other Targets - Lesinurad

Lesinurad

CAS No. 878672-00-5

Lesinurad( RDEA594 )

Catalog No. M19217 CAS No. 878672-00-5

Lesinurad is a selective inhibitor of uric acid reabsorption which is used in combination with other agents in the therapy of gout.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	29	In Stock
10MG	37	In Stock
25MG	73	In Stock
50MG	126	In Stock
100MG	204	In Stock
200MG	304	In Stock
500MG	510	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Lesinurad
Note

Research use only, not for human use.
Brief Description

Lesinurad is a selective inhibitor of uric acid reabsorption which is used in combination with other agents in the therapy of gout.
Description

Lesinurad is a selective inhibitor of uric acid reabsorption which is used in combination with other agents in the therapy of gout. Lesinurad has had a limited clinical use but has not been associated with serum enzyme elevations during therapy or with instances of clinically apparent liver injury.
In Vitro

——
In Vivo

——
Synonyms

RDEA594
Pathway

Others
Target

Other Targets
Recptor

OAT1| OAT3
Research Area

Metabolic Disease
Indication

——

Chemical Information

CAS Number

878672-00-5
Formula Weight

404.28
Molecular Formula

C17H14BrN3O2S
Purity

>98% (HPLC)
Solubility

DMSO : ≥ 39 mg/mL; 96.47 mM
SMILES

C1CC1c1ccc(c2ccccc12)n1c(nnc1Br)SCC(=O)O
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Tan, et al.[abstract]. Arthritis Rheum 2013;65 Suppl 10 :1723.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Osteogenic Growth Pe...

Osteogenic Growth Peptide, OGP is a short, naturally occurring 14-mer growth factor peptide found in serum at μM concentrations. Osteogenic growth peptide OGP is a key factor in the mechanism of the systemic osteogenic response to local bone marrow injury.
Pramipexole 2HCl Mon...

Pramipexole Dihydrochloride is the hydrochloride salt of pramipexole, a benzothiazole derivative. As a nonergot dopamine agonist, pramipexole binds to D2 and D3 dopamine receptors in the striatum and substantia nigra of the brain.
(+)-Syringaresinol

(+)-Syringaresinol shows antioxidant potential, it exhibits cytoprotective activity in cultured MCF-7 cells stressed by H2O2.

Sign In Join Free